INTERPRETATION Current sleep measures being administered in typically developing children are also often used in children with CP, but have not been well validated in this group of children.
Sleep disorders have been described as important comorbidities in children with cerebral palsy (CP).
1-3 A systematic review by Novak et al. showed that one in five children with CP have a sleep disorder. 4 The most frequent subtypes of sleep disorders in this population have been reported as disorders of initiation and maintenance of sleep, sleep-wake transition disorders, parasomnias, and obstructive sleep apnoea. 1, 5 Disorders of initiation and maintenance of sleep have been shown to be more frequent in children with spastic quadriplegia and dyskinetic CP and visual impairment, because of a delayed surge in nocturnal melatonin. 1, 6 Sleep related breathing disturbances are multifactorial with glossoptosis, adenotonsilar hypertrophy, increased muscle tone, and recurrent aspiration, all important contributors. 6, 7 The severity of sleep disorders relates to the functional severity (i.e. Gross Motor Function Classification System [GMFCS] level V). Children with reduced ability to roll in bed and change position may experience more waking, more pain, and be less able to respond to airway obstruction. 6, 7 Pain is one of the most common problems in children with CP. Three in four children with CP have been reported to experience some degree of pain, which is multifactorial and closely linked to the prevalence of sleep problems. 4, 8 Sleep deficiency in children with CP has also been reported to cause sleep deprivation in their caregivers and families, which has resulted in medical health issues such as maternal depression, as well as social and professional life disruption. 8, 9 There is no single measure that can objectively diagnose all sleep disorders. Polysomnography is the criterion standard for objective sleep assessment. It is particularly useful for examining sleep staging, respiration, and limb movements; however, it measures sleep in an artificial setting and fails to identify behavioural sleep disturbances. 10 Actigraphy may provide a more accurate estimation of nocturnal wake times, whereas subjective measures such as questionnaires and diaries can be cost-effective, providing information about sleep habits and behaviours. 11 As most sleep measures have been developed in populations of typically developing children, it is unclear whether these are valid measures in children with neurological disabilities, particularly CP. The limited availability of polysomnography in clinical settings makes it very reasonable to use other more available options. Use of evaluation tools with no proven validity and reliability impacts negatively on any given information and results. Valid sleep assessment tools are needed to guide clinical decisions, interventions, and confirm epidemiological data.
Sleep assessment tools with strong psychometric properties validated in children with CP are critical to adequately evaluate and diagnose sleep disturbances. In order to be standardized, these sleep disorders should correspond to the International Classification for Sleep Disorders (ICSD) or include the sleep related definitions by the International Classification of Functioning, Disability and Health (ICF).
Previous systematic reviews have evaluated the psychometric properties of subjective tools to assess sleep issues in healthy infants and children. 10, 12 These reviews have found insufficient psychometric data available for five sleep measures used in typically developing children as well as an absence of longitudinal data. Those sleep measures have also failed to take into consideration age and developmental differences that may have an impact on any sleep habits and behaviours. 10 Another systematic review outlined the high prevalence of sleep disorders in children with multiple disabilities, and the need for adequately validated tools in these populations of children. 13 This systematic review aimed to determine whether any parent and child report sleep measure tools have been validated in children aged 0-18 years with CP.
METHOD Search strategy
The following databases were searched on November 30th, 2016 and June 1st, 2017: CINAHL, EMBASE, MED-LINE via PubMed, Web of Science, and PsycINFO. The searches were not limited by date, publication status, or study design. The search was limited to publications in English or Spanish. The search strategy combined terms for CP with generic terms for sleep disorders in children. Targeted scanning of citations and relevant references was also used to minimize the chance of missing key studies. The search strategy for PubMed, Embase, and CINAHL is reported in Appendix SI, online supporting information.
Inclusion/exclusion criteria
The inclusion criteria were: (1) population: children 0-18 years with CP; (2) use of any tool that evaluates sleep disorders based on the ICSD 2nd or 3rd editions, 14, 15 or sleep related definitions as described by the ICF; 16 (3) at least 40% of the tool should evaluate sleep according to ICSD 2nd or 3rd editions or ICF definitions; (4) the assessment has published psychometric data about validity (content, construct, and criterion) and reliability (internal consistency, test-retest, interrater, and intrarater reliability) for children 0 to 18 years with CP or psychomotor delay.
The exclusion criteria were: (1) studies were performed in an adult population; (2) trials assessed management or treatment modalities; (3) not published in English or Spanish. When studies were done in populations of children with other neurological or psychiatric disorders, autism spectrum disorder, or attention-deficit-hyperactivity disorder, these would be considered if there was inclusion of any subpopulation of children with CP.
Methods of data extraction
The first author carried out the search in the databases described. After an initial review, most publications were excluded based on title and abstract. The initial preselection included papers that assessed sleep in children with CP. From these publications, full texts were retrieved for further scrutiny. The second author undertook an independent review. Several publications were excluded because of incomplete peer reviewed publications and where the studies focused on prevalence of sleep disorders but no validation of any tools. Conflicting viewpoints were discussed among the four authors until consensus was reached. Some studies that used a measure specifically developed for their studies were excluded because no psychometric properties were described. The papers that did not measure sleep corresponding with any of the definitions of the ICSD, or the sleep-related definitions as described by the ICF, were also excluded. From the remaining publications, all the sleep measures used were classified as condition specific for CP, multiple disability related, or generic. Full versions of the questionnaires were accessed if not included in the publications. The sleep measures used in the final selection of papers were assessed for any available psychometric data in children with CP ( Fig. 1 ). An additional search was performed to evaluate the psychometric properties of identified measures. Since the psychometric properties of these measures have not been comprehensively studied in children with CP, a new search was performed on the psychometric properties of the selected measures in typically developing children.
What this paper adds
• There are no condition specific measures of sleep in children with cerebral palsy (CP).
• The Schlaffragebogen f€ ur Kinder mit Neurologischen und Anderen Komplexen Erkrankungen (SNAKE) questionnaire is validated for children with CP in Gross Motor Function Classification System level V.
• A framework to design a CP specific sleep questionnaire is provided. For each selected measure, data was extracted on the primary purpose of the measure (discriminative, evaluative, or predictive), type of measure (screening or diagnostic), dimension of sleep measured, initial target population in which measure was developed, age range in which measure has been used, availability of the measure, and scoring system including a cut-off. From all the papers using the same sleep measure, psychometric properties were extracted and rated on methodological quality using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist with 4-point scale. 17, 18 These are classified as excellent, good, fair, or poor based on the checklist. Each quality was given the highest possible rating available in any of the publications. A methodological quality score per box was obtained by taking the lowest rating of any item in a box ('worse score counts') as suggested by the COSMIN guidelines.
Validity data was considered appropriate when Cronbach's alpha was between 0.75 and 0.95. Criterion validity was considered 'good' when correlation with a criterion standard measure was greater than or equal to 0.7. Reliability was considered adequate when intraclass correlation coefficient for continuous variables or weighted Cohen's Kappa coefficient for ordinal measures were greater than or equal to 0.7. The minimum sample size recommended was 50 participants. The adequate time interval between independent measures was 2 to 3 weeks. When any of these values were given but was not satisfactory, the overall score for that specific property was reduced by one category in the COSMIN scoring.
The clinical utility, which is not part of the COSMIN guidelines, was described for each instrument in terms of time needed to complete the measure, person completing the measure, need for a manual or training, scoring system, and cost. The clarity of instructions was rated based on the adapted quality analysis outcome measures rating form developed by CanChild Centre for Disability Research at McMaster University.
RESULTS
From the 1176 publications identified, only one paper met all inclusion criteria providing psychometric data from a population of children with CP. It used the Schlaffragebogen f€ ur Kinder mit Neurologischen und Anderen Komplexen Erkrankungen (SNAKE) questionnaire.
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Another 16 papers used sleep measures in this population but had limited psychometric data (Fig. 1) . The five sleep measures used in these publications were the Children Sleep Habits Questionnaire (CSHQ), the Pediatric Sleep Disturbance Questionnaire (PSDQ), the Pediatric Sleep Questionnaire (PSQ), the Sleep Disturbance Scale for Children (SDSC), and the SNAKE questionnaire. All 17 included papers and their population characteristics are described in Table I . None of the measures were condition specific for CP even though SNAKE assesses multiple disabilities. The SNAKE had no specific data for children with CP. The characteristics of the included measures are described in Table II . A description of the domains related to the ICSD 3rd edition and ICF are provided in Table II . The current review used the COSMIN checklist, 17, 18 which was developed in an international Delphi study as a multidisciplinary, international collaboration. It is used to assess the quality of the available evidence on the measurement properties of different measurement instruments. Its main focus is on health-related patient-reported outcomes, but the checklist is also useful for evaluating studies on other health measurement instruments. Steps 1 to 4 were followed. Boxes C (measurement error), G (cross cultural validity), and I (responsiveness) were not included. Interpretability and generalizability boxes were recommended to extract data but no scoring system was developed. Based on this checklist, the studies evaluating sleep in children with CP had variable methodological quality (Table SI, online supporting information). This was primarily fair or poor, mostly because the papers refer to publications validated in other populations. There was limited psychometric data within the selected papers for children with CP. The SDSC and SNAKE questionnaires were initially developed in Italian and German respectively. 19, 20 An English version of the SDSC questionnaire was provided within the initial publication, but there was no description about its translation process. 20 It has been validated in multiple languages other than English. [21] [22] [23] [24] In the case of the SNAKE questionnaire, its cross-cultural validity to other languages including English has not yet been tested. Back translation was used twice, 19 but there was no description of the expertise of the translators or information about how differences between translators were resolved. 19 No pretest has been performed to check the interpretation and cultural relevance of the items, and the ease of comprehension in English.
Reliability
The methodological quality for the SNAKE questionnaire was 'fair'. It was initially tested on children admitted to hospital. The time interval for the retest was 8 weeks but it was unclear what the retest conditions were. There was no comment about reasons for admission to hospital or length of stay in hospital. 19 The methodological quality of the studies assessing all the other tools in children with CP was poor given that there is insufficient information in this population (Table SI, online supporting information) .
Some data was available for typically developing children. In this population, test-retest reliability and internal consistency were adequate for the CSHQ, PSQ, and SDCS. The internal consistency for the CSHQ-Toddler was poor. The test/retests values of the SNAKE questionnaire in children with multiple neurological disabilities were broad (0.31-0.79; Table III) . 19 
Validity
The CSHQ, PSQ, and SDSC included items that were all relevant for typically developing children, but no assessment was performed for their validity in children with CP. All the items from the SNAKE were relevant for children with CP. Factor analysis was performed for all the measures, but SNAKE was the only one to undertake factor analysis for children with CP. 19 In terms of criterion validity, only the CSHQ, PSQ, and SDSC had information regarding specificity and sensitivity in typically developing children. 20, [25] [26] [27] [28] No information was available for children with CP. Evidence for content, construct (structural validity and hypotheses testing), and criterion validity in children with CP and typically developing children are provided in Table IV .
Interpretability
Cut-offs and change scores were provided for the CSHQ and the SDSC in typically developing children. The SNAKE questionnaire has been validated in children with severe psychomotor impairment, corresponding to GMFCS level V. No children with less severe disability were considered.
Clinical utility
Only three measures had reported information about completion time ranging from 15, 20, and 30 minutes for the SDSC, SNAKE, and PSQ respectively. Apart from the PSDQ, which is completed by the patients, all the other tools are to be completed by the parents or carers. None of the tools had any cost. The SNAKE questionnaire and the PSQ have a manual and instructions available separately. 10, 29 In the case of the SNAKE, the instructions on the manual are comprehensive but complex, and require a multiple step process before giving any scores. Instructions for the CSHQ were included within the questionnaire. The PSDQ had no explicit instructions for its use and these had to be inferred from the publication. 30 The SDSC provides instructions within the questionnaire, which were clear and concise. SDSC showed excellent utility, whereas the PSDQ had poor utility. The remaining three measures had adequate utility based on the rating form developed by CanChild Centre (Table SII , online supporting information). All except the SNAKE questionnaire have provided factor loading for individual questions. These related to some sleep disorders as well as some functional aspects of sleep. The questions with factor loadings greater than 0.6 are provided (Table SIII, online supporting information) . These represent the best questions within each questionnaire evaluating some specific aspect of sleep.
DISCUSSION
This systematic review identified five sleep measures (the CSHQ, PSDQ, PSQ, SDSC, and SNAKE questionnaire) that have been utilized for children with CP. In terms of these measures, there was limited psychometric data for their use in children with CP. Data was grouped and analysed from all the relevant publications that used these measures.
Three of the five measures evaluated in our systematic review (the CSHQ, PSQ, SDSC) had been previously assessed by Lewandowski et al. for their use in the general paediatric population. These were categorized as multidimensional sleep measures and received a 'well established' rating based on the evidence-based assessment developed by the American Psychology Association Task Force. 10 The PSQ was validated against polysomnography, 27 and the SDSC validated against actigraphy (in the Portuguese version). 21 Both the SDSC and the CSHQ differentiated between clinical and control groups. The SDSC showed good general diagnostic accuracy (area under the receiver operating characteristics curve=0.91). 20 The three questionnaires have shown good internal consistency in typically developing children. While the PSQ had adequate reliability in this population, 26, 27 the Spearman correlations for the CSHQ and SDSC were lower. 20, 25 No assessment was performed for any specific subpopulation groups, thus limiting their generalizability to children with CP.
Validity and reliability of the CSHQ, PSDQ, PSQ, and SDSC have been poorly tested in children with CP. One of the main limitations, when using these questionnaires with the CP population, is that they relied on factor analysis performed in typically developing children with no inclusion of children with CP. 20, [25] [26] [27] 30 Factor analysis for CSHQ has only recently been completed in typically developing toddlers. 31 Validity data for the PSQ has only been provided for the sleep related breathing disorders and restless leg syndrome scales. 26, 27 The SDSC questionnaire has been validated in multiple languages but not in English, [21] [22] [23] [24] while the SNAKE questionnaire has only been validated in its German version. 19 To date, a sleep questionnaire has therefore not been validated in an English-speaking sample of children with CP.
Sensitivity and specificity for the CSHQ, PSQ, and SDSC have only been tested in typically developing children 24, 25, 28, 32 and cannot be generalized to other populations. No specificity or sensitivity have been provided for the PSDQ 30 or the SNAKE questionnaire. 19 Interpretability was also considered to be poor across all measures based on the COSMIN guidelines. Even though the CSHQ and SDSC have cut-offs for the general population, these have not been confirmed in children with CP. On the other hand, the SNAKE questionnaire has only been validated in children with severe psychomotor impairment, thus limiting its use in less physically disabled children. 19 From all the measures assessed in this review there was no specific tool that demonstrated strong psychometric properties in all areas. The SNAKE questionnaire has only been validated in German with no cross-cultural validity tested in English. 19 It had the best methodological quality regarding its validity, particularly structural and criterion validity, as well as its internal consistency. The quality was however poor for its test-retest, interrater, and intrarater reliability as well as hypothesis testing. The time interval between measures was 8 weeks, which may be excessive, given that a significant number of the children included in the sample were inpatients and it is uncertain whether the medical status of the participants changed before retesting. 19 The five measures included were screening tools with their main purpose being discriminative. There was a broad age range with the SNAKE and PSQ not taking into account any differences in developmental stages. Utility was estimated as poor for the PSDQ, as it is the patients (9-20y) and not their parents who completed the PSDQ. The duration of time to complete the questionnaire is unclear, and there were no instructions. On the other hand the SDSC was very concise, easy to administer, and includes a scoring sheet.
There were a lot of similarities in terms of the domains assessed when these were related to ICF definitions. These included onset of sleep, quality of sleep, maintenance of sleep, functions involving the sleep cycle, and involuntary muscle contractions. Even though some of the questions have been developed in populations of typically developing children, these would still be applicable for other groups including children with CP. A total score would, however, not be able to discriminate for any specific issues in individual domains.
Domains related to ICSD 3rd edition were also similar. Most measures included items evaluating for parasomnias, which may not be relevant for the whole spectrum of children with CP. The PSQ, SDSC, and SNAKE questionnaire also include questions for central disorders of hypersomnolence. The latter in particular contains specific questions that take into account epilepsy, pain, and repositioning.
Most of the currently available sleep tools were not designed to assess children with associated medical conditions. These do not take into consideration the differences in children with CP, regarding their level of functionality and associated medical complications such as epilepsy, gastro-oesophageal reflux, muscle spasms, scoliosis, and medications. Even though the SNAKE questionnaire targets children with psychomotor impairment, it does not make a distinction for their age or developmental stage, which could influence the prevalence of sleep disorders, and does not evaluate children with CP across the full spectrum of functional ability (GMFCS I-V).
In clinical practice, there are no condition specific tools to assess sleep in children with CP, and all the measures used still need adequate validation in this population. This limits their applicability in clinical practice. Even though these measures are only discriminative and have not been designed to specifically diagnose any functional disturbances, some of their questions correlate well with functional aspects of sleep that could be generalized to many populations. Combining the use of these tools with adequate history taking could be potentially useful to measure change overtime.
For the clinician, until a condition specific sleep measure is developed for children with CP, use of the above-mentioned tools could still be useful. It is difficult to predict their real benefit, however, when screening for any sleep disorders in children with CP. For children who are in GMFCS level V, it may be reasonable to use the SNAKE questionnaire. Children in GMFCS levels III and IV are likely to share many of the comorbidities of children in GMFCS level V, regarding mobility, pain, breathing difficulties, etc., and could also benefit from using this questionnaire. Children with CP in GMFCS levels I-II are likely to share more in common with typically developing children, and therefore the CSHQ, PSQ, and SDSC could be useful screening sleep measures in these subgroups, when combined with questions about pain, positioning, seizures, etc.
In research, any information given through the use of these tools may not be psychometrically sound. The lack of validated properties in children with CP limit the interpretation of results about the epidemiology of sleep disorders in this population. Particularly, the CSHQ, PSQ, and SDSC have been widely used in research of children with CP. Even though they take into consideration general information about sleep, it is uncertain if these could reliably categorize the children with CP who have a sleep disorder. The SNAKE questionnaire has potential for use in further trials. It remains however a discriminative tool, only validated in German, with untested sensitivity or specificity. It has been tested in children at GMFCS level V, but validation across all other GMFCS levels of CP is still required.
There is an increasing need for the development of condition specific tools in the assessment of sleep disorders, particularly in children with CP. Any tool developed in the future for this population of children should take into account some important points: (1) it should be based on definitions given by the ICSD and related definitions given by ICF; (2) it should consider their differences given by age, cognition, and developmental stage as well as their type of CP and GMFCS; (3) the measure should focus on the relevant areas of sleep to be impacted, as those categorised by Galland et al., and L elis et al., which represent the common sleep problems in this population of children 6, 7 ; (4) the measure should have screening and diagnostic use; (5) its primary purpose should ideally be evaluative and predictive rather than just discriminative; (6) the questionnaire should be validated based on well-designed guidelines such as the COSMIN guidelines; (7) there should be clear hypotheses being tested; (8) it should take a short time to complete and have a scoring system easy to apply; (9) the tool should be tested parallel to other objective sleep measures such as polysomnography or actigraphy.
Some of the questions in these questionnaires have great potential to help predict specific sleep disorders in other populations of children such as those with CP. The questions with the best factor loading from all the questionnaires related to some specific sleep disorders but also to functional aspects of sleep. These may be starting points in the construction of a condition specific questionnaire of sleep disorders in children with CP.
There are multiple potential limitations to this review that increase the risk of publication bias. Articles were only included if these were published in English or Spanish, which means that some potential publications in other languages with relevant psychometric data could have been missed. Some measures were also excluded because the authors could not be contacted and the measures, including information about their psychometric properties, could not be accessed. Some potential tools may not therefore have been included. The lack of psychometric data in children with CP resulted in extrapolation of data from typically developing children. The search for publications in this group of children was not as comprehensive and has a high potential for citation and availability bias.
The majority of the publications included have poor methodological quality and therefore a high risk of bias. All the studies lacked the use of a concurrent control group and did not have well defined inclusion or exclusion criteria, resulting in potentially high recruitment and selection bias. Sample sizes were also small and were another potential cause for bias.
CONCLUSION
This systematic review identified five sleep measures that assess sleep in children with CP. There are no condition specific measures for this population. Most of the measures had limited available psychometric data in this group of children. The PSQ and SDSC had the strongest psychometric properties in typically developing children. No measure has been thoroughly validated in children with CP despite their general use. The SDSC and SNAKE questionnaire still need to be validated in English. Future sleep tools should take into consideration many of the intrinsic and extrinsic factors associated to sleep disturbances in this group of children. 
SUPPORTING INFORMATION
The following additional material may be found online:
Appendix SI: Search strategy for PubMed, Embase, and CINAHL 
